Global Plasma Fractionation Market to reach USD 35.67 billion by 2026

Global Plasma Fractionation Market Size Study, by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Proteases Inhibitors, Others) by Application (Neurology, Immunology, Homology, Critical Care, Pulmonology, Rheumatology, Others) by End Use (Hospitals & Clinic, Clinical Research Laboratories, Academic Institutes) by Regional Forecasts 2019-2026
Product Code:  HALMD_20079440
Chapter 1.	Executive Summary  
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1.	Plasma Fractionation Market, by Product, 2017-2026 (USD Billion)
1.2.2.	Plasma Fractionation Market, by Application, 2017-2026 (USD Billion)
1.2.3.	Plasma Fractionation Market, by End-Use, 2017-2026 (USD Billion)
1.2.4.	Plasma Fractionation Market, by Region, 2017-2026 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Plasma Fractionation Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Plasma Fractionation Market Dynamics	
3.1.	Plasma Fractionation Market Impact Analysis (2018-2026)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Plasma Fractionation Market Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Plasma Fractionation Market by Product 
5.1.	Market Snapshot 
5.2.	Global Plasma Fractionation Market by Product, Performance - Potential Analysis
5.3.	Global Plasma Fractionation Market Estimates & Forecasts by Product 2016-2026 (USD Billion)
5.4.	Plasma Fractionation Market, Sub Segment Analysis 
5.4.1.	Immunoglobulin
5.4.2.	Coagulation Factor Concentrates 
5.4.3.	Albumin 
5.4.4.	Protease Inhibitors 
5.4.5.	Others
Chapter 6.	Global Plasma Fractionation Market by Application 
6.1.	Market Snapshot 
6.2.	Global Plasma Fractionation Market by Application, Performance - Potential Analysis
6.3.	Global Plasma Fractionation Market Estimates & Forecasts by Application, 2016-2026 (USD Billion)
6.4.	Plasma Fractionation Market, Sub Segment Analysis
6.4.1.	Neurology 
6.4.2.	Immunology 
6.4.3.	Homology 
6.4.4.	Critical Care 
6.4.5.	Pulmonology 
6.4.6.	Hemato-Oncology 
6.4.7.	Rheumatology 
6.4.8.	Other Applications
Chapter 7.	Global Plasma Fractionation Market by End-Use 
7.1.	Market Snapshot 
7.2.	Global Plasma Fractionation Market by Application, Performance - Potential Analysis
7.3.	Global Plasma Fractionation Market Estimates & Forecasts by Application, 2016-2026 (USD Billion)
7.4.	Plasma Fractionation Market, Sub Segment Analysis
7.4.1.	Hospitals & Clinics 
7.4.2.	Clinical Research Laboratories 
7.4.3.	Academic Institutes
Chapter 8.	Global Plasma Fractionation Market, Regional Analysis
8.1.	Plasma Fractionation Market, Regional Market Snapshot 
8.2.	North America Plasma Fractionation Market 
8.2.1.	U.S. Plasma Fractionation Market
8.2.1.1.	Product breakdown estimates & forecasts, 2016-2026
8.2.1.2.	Application breakdown estimates & forecasts, 2016-2026
8.2.1.3.	End-Use breakdown estimates & forecasts, 2016-2026
8.2.2.	Canada Plasma Fractionation Market
8.3.	Europe Plasma Fractionation Market Snapshot
8.3.1.	U.K. Plasma Fractionation Market
8.3.2.	Germany Plasma Fractionation Market
8.3.3.	Rest of Europe Plasma Fractionation Market
8.4.	Asia-Pacific Plasma Fractionation Market Snapshot
8.4.1.	China Plasma Fractionation Market 
8.4.2.	India Plasma Fractionation Market 
8.4.3.	Japan Plasma Fractionation Market
8.4.4.	Rest of Asia Pacific Plasma Fractionation Market
8.5.	Latin America Plasma Fractionation Market Snapshot
8.5.1.	Brazil Plasma Fractionation Market
8.5.2.	Mexico Plasma Fractionation Market
8.6.	Rest of The World Plasma Fractionation Market
Chapter 9.	Competitive Intelligence
9.1.	Top Market Strategies
9.2.	Company Profiles
9.2.1.	CSL
9.2.1.1.	Key Information
9.2.1.2.	Overview
9.2.1.3.	Financial (Subject To Data Availability)
9.2.1.4.	Product Summary
9.2.1.5.	Recent Developments
9.2.2.	Grifols 
9.2.3.	Shire 
9.2.4.	Octapharma 
9.2.5.	Kedrion 
9.2.6.	LFB
9.2.7.	Biotest 
9.2.8.	Sanquin 
9.2.9.	China Biologic Products 
9.2.10.	Bio Prodcuts Laboratory (BPO)
9.2.11.	Japan Blood Products Organization 
9.2.12.	Green Cross Corporation 
9.2.13.	Shanghai Raas Blood Products
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.2.	Research Attributes
10.3.	Research Assumption

Global Plasma Fractionation Market valued approximately USD 21.55 billion in 2018 is anticipated to grow with a healthy growth rate of more than 6.50% over the forecast period 2019-2026. Fractionation is a process which is conducted to separate specific quantity of mixture. Whereas, plasma is the fluid element of the blood, which is fractionated to get different plasma derivatives such as immunoglobulins, albumin and others. These derivative plasma products have medicinal effects and are used in the medication of several blood plasma related disorders. For example, coagulation factor VIII is a plasma derivative, which is employed for the treatment and prophylaxis of hemophilia. Also, it is employed to stop extreme blood loss throughout the surgical procedures. Key factors which are providing growth to the market are the increasing use of immunoglobulins in several therapeutic areas, increasing respiratory diseases, growing geriatric population across the world, and AATD driving the approval of alpha-1-antitrypsin, and growing plasma collection. However, limited reimbursement policies and high cost, are the major restraining factor which hinder the growth of this market.
The regional analysis of Global Plasma Fractionation Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia-Pacific is the fastest growing region across the world in terms of market share. Whereas, owing to the countries such as U.S. and Canada, North America region is anticipated to be the dominating region over the forecast period 2019-2026.

The leading players of the market included in this report are:
CSL
Grifols
Shire
Octapharma
Kedrion
LFB
Biotest
Sanquin
China Biologic Products
Bio Prodcuts Laboratory (BPO)
Japan Blood Products Organization
Green Cross Corporation
Shanghai Raas Blood Products

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Products:
Immunoglobulin
Coagulation Factor Concentrates
Albumin
Protease Inhibitors
Others

By Application:
Neurology
Immunology
Homology
Critical Care
Pulmonology
Hemoto-Oncology
Rheumatology
Others

By End Use:
Hospitals & Clinics
Clinical Research Laboratories
Academic Institutes

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Plasma Fractionation Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…